Roche targets continued growth after strong 2024 sales

Roche achieved a sales growth of 7% (3% in CHF) in 2024, citing strong demand for pharmaceutical products.

Feb 1, 2025 - 06:00

Roche targets continued growth after strong 2024 sales

Roche achieved a sales growth of 7% (3% in CHF) in 2024, citing strong demand for pharmaceutical products.

Read the original article

Tags:

Previous Article

Rentschler closes UK cell and gene therapy facility and does a pivot to biologics

All change in Germany – confidential pricing in, IRP out

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

FDA approves BeiGene’s TEVIMBRA for oesophageal cancer

FDA approves BeiGene’s TEVIMBRA for oesophageal cancer

Mar 16, 2024

STAT+: Apple Watches are back on sale while federal court reviews patent suit

STAT+: Apple Watches are back on sale while federal cou...

Dec 27, 2023

Cidara to continue its CD388 influenza programme despite Janssen’s contrary decision

Cidara to continue its CD388 influenza programme despit...

Jul 21, 2023